• Drosophila Keap1 Nuclear Condensates Under Stress

  2026-09-10

  A 2026 study in Antioxidants shows that Drosophila Keap1 assembles stable nuclear condensates after oxidative stress, linking its stress-response role with nuclear organization. Live imaging, FRAP, domain analysis, and in vitro reconstitution identify the N- and C-terminal regions, including intrinsically disordered regions, as key determinants of this behavior.

• Epinephrine Bitartrate: Research Workflows

  2026-09-10

  Epinephrine Bitartrate enables controlled studies of vascular tone, cardiac signaling, airway responses, and adrenergic receptor biology across concentration-resolved assays. This guide translates its non-selective pharmacology into practical workflows while adapting supply-stewardship lessons from local-anesthetic research without treating the formulations as interchangeable.

• SERT–nNOS Blockade and Rapid Antidepressant Effects

  2026-09-09

  The reference study identifies esflurbiprofen as a candidate fast-onset antidepressant by screening for compounds that disrupt the serotonin transporter–neuronal nitric oxide synthase interaction in the dorsal raphe nucleus. Its combination of mBRET screening, stress-model pharmacology, molecular analysis, and resting-state fMRI connects target engagement with serotonergic circuit and behavioral changes, while leaving clinical translation unresolved.

• Hoechst 33342/PI Double Staining Kit Guide

  2026-09-09

  The Hoechst 33342/PI Double Staining Kit provides a dual-fluorescence workflow for distinguishing nuclear chromatin changes from loss of cell membrane integrity in cultured samples. It is intended for research use in fluorescence-based cell death studies, not for diagnostic, clinical, or medical decision-making.

• Angiotensin I Workflows for RAS Research

  2026-09-08

  Build reproducible renin-angiotensin system experiments around Angiotensin I as a defined substrate for ACE conversion, cardiovascular pathway studies, and antihypertensive screening. The workflow also shows how recent peptide-binding findings can guide carefully controlled cross-domain assays without confusing precursor activity with downstream Ang II effects.

• Engineering a Single-Component Bitespiramycin Strain

  2026-09-08

  Ma et al. simplified bitespiramycin biosynthesis by deleting part of the sspA 3-O-acyltransferase gene in Streptomyces spiramyceticus WSJ-1. The resulting WSJ-2 strain preferentially produced 400-isovalerylspiramycin I, illustrating how targeted pathway engineering can reduce antibiotic component complexity and improve downstream characterization.

• HA-LNP PTEN mRNA for Transdermal Immunotherapy

  2026-09-07

  The reference study develops a hyaluronate-conjugated lipid nanoparticle in which HA-DMG replaces conventional PEG-lipid functions while enabling CD44-oriented delivery of PTEN mRNA through skin. In a melanoma model, topical PTEN mRNA@HA-LNP restored tumor-suppressor expression, promoted immunogenic cell death, activated antitumor immunity, and reduced tumor growth with limited reported toxicity.

• Etomoxir: From FAO Inhibition to Translational Design

  2026-09-07

  Etomoxir and R-(+)-Etomoxir provide a powerful framework for connecting mitochondrial fatty acid oxidation with immune function, lipid remodeling, and neuroinflammatory disease models. This thought-leadership guide explains how to interpret CPT-1 inhibition, design whole-blood and cellular assays, manage DGAT-related confounding, and translate findings without overstating therapeutic relevance.

• N2703 in Adipose-Neural Cardiac Assays

  2026-09-05

  Use 3-(1-methylpyrrolidin-2-yl)pyridine (N2703) as a controlled perturbation in adipocyte–neuron–cardiomyocyte experiments inspired by an emerging arrhythmia mechanism. A staged workflow combines solvent discipline, pathway controls, electrophysiology, calcium imaging, and viability gates so exploratory findings are not mistaken for target validation.

• Cytosolic DNA Rewires TDP-43 Homeostasis

  2026-09-04

  The reference study identifies cytosolic DNA accumulation as a trigger of TDP-43 condensate formation, nuclear depletion, and production of a short TDP-43 isoform. Its findings connect DNA mislocalization, nuclear transport, phase separation, and ALS-linked TDP-43 dysfunction, while offering a framework for studying DNA damage-related mechanisms in neurodegeneration.

• Budesonide B1900 for Reliable Cell Assays

  2026-09-04

  Learn how Budesonide (SKU B1900) can help researchers distinguish anti-inflammatory activity from assay artefacts in viability, proliferation, and airway inflammation studies. This scenario-based guide covers solvent compatibility, stock preparation, protocol controls, permeability-model interpretation, and practical supplier selection.

• Negative Electrostatics in α-Synuclein Condensates

  2026-09-03

  The reference study shows that α-synuclein condensates are not electrostatically neutral compartments: their strongly negative potential controls the partitioning of proteins, fluorophores, and small molecules. By combining charge-varied probes, zeta-potential analysis, and a differentiated SH-SY5Y model, the work provides a framework for interpreting condensate composition and designing fluorescence-based experiments.

• Mecamylamine hydrochloride for Gut-Brain Studies

  2026-09-03

  Mecamylamine hydrochloride provides a practical pharmacological stress test for nicotinic acetylcholine receptor signaling in neuronal, gut-brain, and neuropsychiatric models. This guide connects receptor-level assays with vagal recordings, microbiota experiments, seizure phenotyping, and troubleshooting strategies while clearly separating reported evidence from workflow recommendations.

• Hexetidine (NSC-17764) for Oral Biofilm Assays

  2026-09-02

  Hexetidine (NSC-17764) supports strain-aware planktonic testing, Candida work, and biofilm inhibition assays in oral microbiology. Its distinctive value is the opportunity to quantify copper synergy while preserving practical controls for solubility, inoculum effects, and biofilm readout variability.

• NSP15 Inhibitor Screening: Thymopentin and Oleuropein

  2026-09-02

  The 2021 reference study used structure-based virtual screening and molecular dynamics to prioritize natural products that may inhibit the SARS-CoV-2 endoribonuclease NSP15. Thymopentin and oleuropein produced the most favorable computational profiles, but the findings remain a preclinical hypothesis requiring biochemical, cellular, and pharmacokinetic validation.

8105 records 1/541 page Next 12345 下5页 Last page